4 company-specific changes
fiscal period 2025-12-31
filed 2026-02-24
- Removal of detailed credit concentration risk disclosure across borrowers, industries, geographies, and collateral types signals reduced or resolved credit risk concerns that investors rely on.
- Removal of material mortgage repurchase obligation risk. Suggests Fifth Third resolved or substantially mitigated a contingent liability that previously warranted reserve establishment.
See the full detail →
3 company-specific changes
fiscal period 2025-12-31
filed 2026-02-24
- New explicit disclosure of health/wellness trends and weight-loss medications affecting consumer behavior, menu acceptance, and brand perception—a material market risk escalation.
- Added explicit reference to "anti-American sentiment" as a newly disclosed geopolitical risk factor affecting consumer demand and operations globally.
See the full detail →
2 company-specific changes
fiscal period 2025-12-31
filed 2026-02-24
- Asbestos claims pending increased 15% year-over-year from 690 to 795, indicating escalating litigation exposure and potential reserve requirements.
- Largest customer concentration increased from 15% to 18% of net sales, materially heightening customer concentration risk and dependency.
See the full detail →
4 company-specific changes
fiscal period 2025-12-31
filed 2026-02-24
- Material acquisition (Hess, closed July 2025) introduces substantive integration, synergy realization, and operational disruption risks that could adversely impact financial results and shareholder returns.
- Removal of Hess acquisition risk indicates deal closed or abandoned. Material resolution of major strategic transaction uncertainty affecting shareholder value.
See the full detail →
9 company-specific changes
fiscal period 2026-01-03
filed 2026-02-24
- New 2025 tariffs, Mexico production shift with tariff exposure, China rare earth export restrictions causing actual component delays and shortages—concrete escalation from hypothetical risk.
- New $108.4M impairment charge in 2025 driven by brand prioritization strategy shift affecting major trade names (Lenox, Troy-Bilt, Irwin). Indicates worsening asset valuations and strategic reassessment.
See the full detail →
4 company-specific changes
fiscal period 2025-12-31
filed 2026-02-24
- New disclosure of material power innovation and data center projects with distinct risks: stranded assets, specialized equipment sourcing, contractual penalties, and evolving regulations.
- Added explicit disclosure of regulatory/administrative action risks (rate complaints, tariff reductions, volume decreases) and new Transco offshore "IT feeder" rate competitive disadvantage risk.
See the full detail →
7 company-specific changes
fiscal period 2025-12-31
filed 2026-02-24
- China Gardasil sales collapsed from expected decline to actual significant decline with no material recovery expected in 2026, materially worsening revenue risk.
- Newly disclosed material revenue losses: Bridion U.S. exclusivity moved from 2026 to July 2026 with expected discontinuation by end-2026; Januvia/Janumet exclusivity losses in May/July 2026 with near-total U.S. sales loss expected; Keytruda biosimilar competition accelerated to 2028-2029. Substantive worsening of competitive timeline and magnitude.
See the full detail →
5 company-specific changes
fiscal period 2025-12-31
filed 2026-02-24
- Outstanding debt increased 15% ($16.0B to $18.4B). New disclosure of pending Masimo acquisition financing adds concrete debt risk. Available borrowing capacity slightly decreased.
- Company now explicitly discloses failure to meet historical acquisition rates over past years and ongoing inability to do so, escalating from hypothetical risk to demonstrated operational shortfall.
See the full detail →
3 company-specific changes
fiscal period 2025-12-31
filed 2026-02-24
- New disclosure of material Russia exposure: 5% sales, 7% assets, 30% cash held in Russia, $30M interest income. Sanctions, capital controls, supply disruption, asset seizure risk, and Ukraine conflict create substantive geopolitical and operational risks.
- New specific disclosure of PFAS litigation and silica dust claims with potential remediation costs and injunctive relief exposure.
See the full detail →
8 company-specific changes
fiscal period 2025-12-31
filed 2026-02-24
- Newly disclosed $32B multi-year U.S. manufacturing/R&D investment with material execution risks: delays, cost inflation, regulatory compliance, skilled labor constraints, and potential asset impairments.
- Multiple new material regulatory and pricing risks: Biktarvy selected for Medicare negotiation (2028), OBBB Act Medicaid changes, tariff threats, MFN pricing agreements, and PEPFAR/CDC funding cuts.
See the full detail →
4 company-specific changes
fiscal period 2025-12-31
filed 2026-02-24
- New material risks added: third-party AI provider dependency (pricing, outages, discontinuation), IP protection uncertainty for AI-generated content, commoditization risk, and limited control over critical systems.
- Total debt increased 22.7% ($7,623M to $9,355.9M) and available liquidity declined 21.5% ($3,369M to $2,644M), materially worsening leverage and financial flexibility.
See the full detail →
9 company-specific changes
fiscal period 2025-12-31
filed 2026-02-24
- PAMA reductions frozen for 2026 and capped at 15% annually 2027-2029, versus prior $100M expected reduction in 2026. Material improvement in near-term reimbursement outlook.
- Debt reduced from $6.2B to $5.2B; near-term obligations halved from $1.0B to $500M. Material improvement in leverage position and liquidity.
See the full detail →
3 company-specific changes
fiscal period 2025-12-31
filed 2026-02-24
- Material new risk: 13 GW acquisition significantly expands generation capacity and operational footprint. Integration complexity, management distraction, potential asset impairments, and revenue realization risks are substantive.
- Substantially expanded AI risk disclosure. Added specific risks: third-party vendor failures, IP infringement, data misappropriation, competitive disadvantage from AI adoption lag, model drift, and service outages. Escalates from emerging-tech concerns to material operational and competitive threats.
See the full detail →
2 company-specific changes
fiscal period 2025-12-31
filed 2026-02-24
- Methane Fee program suspended by One Big Beautiful Bill Act (July 2025); EPA eliminated GHG endangerment finding (Feb 2026), reducing near-term regulatory burden and cost risk.
- Added Oil Pollution Act, NEPA, and new administration executive orders signaling policy shift favoring energy production but creating regulatory uncertainty and potential state-level countermeasures.
See the full detail →
7 company-specific changes
fiscal period 2025-12-31
filed 2026-02-24
- New disclosure of two material customer disputes: AT&T Mexico ($300M revenue, $30M reserves, escrow arrangement) and DISH (payment default). Substantive litigation risk newly disclosed.
- New disclosure of customer concentration risk and specific DISH revenue loss (2-4% of property revenue) from spectrum sales and network decommissioning.
See the full detail →
7 company-specific changes
fiscal period 2025-12-31
filed 2026-02-24
- Debt increased 16% ($11.3B to $13.1B). Major acquisition added $7.7B debt, substantially increasing leverage and refinancing risk. Material deterioration in capital structure.
- Removal of material post-acquisition risk disclosure. Worldpay sale completed; transition risks and integration uncertainties no longer apply or have been resolved.
See the full detail →
6 company-specific changes
fiscal period 2025-12-31
filed 2026-02-24
- Significant expansion of risk disclosures: added matched principal intermediary, self-clearing, third-party supplier, M&A integration, key personnel retention, sanctions, and climate risks. Material broadening of disclosed risk profile.
- Added three new substantive IP risks: inability to protect intellectual property, defending against infringement claims, and open-source software litigation exposure.
See the full detail →
1 company-specific change
fiscal period 2025-12-31
filed 2026-02-24
- Escalated disclosure of ZEV mandate enforcement risk, operational curtailment threat, and specific cost impacts (charging infrastructure, fleet modifications) now material to LTL operations.
See the full detail →
7 company-specific changes
fiscal period 2025-12-31
filed 2026-02-24
- New material litigation disclosed: First Solar v. BP Solar for $323.6M breach claim plus counterclaim for $175M. Specific, quantified, and substantial exposure.
- New tariff regimes (IEEPA, Section 122) on key manufacturing countries (Vietnam, India, Malaysia) with rates up to 50%, plus new AD/CVD orders with rates exceeding 3,400%, materially escalate trade risk and have already impacted operations and profitability.
See the full detail →
3 company-specific changes
fiscal period 2025-12-31
filed 2026-02-24
- New explicit disclosure of DeFi, cryptocurrency, and blockchain disruption risks with specific impacts on deposits, liquidity, revenues, and regulatory compliance costs.
- Expanded disclosure of specific geopolitical risks: Venezuela/Latin America instability, US-China competition, economic fragmentation, weaponized sanctions/tariffs, cyber threats to infrastructure, and credit/funding impacts.
See the full detail →
6 company-specific changes
fiscal period 2025-12-31
filed 2026-02-24
- New specific closure announced: Lanaken, Belgium facility with quantified $140M charge through 2027, replacing prior Mechelen closure. Escalates restructuring risk with concrete financial impact.
- Significant escalation of ethylene cartel litigation: 11 new claims filed in 2025-2026 against Celanese by major competitors (Shell, Repsol, TotalEnergies, OMV, Borealis, LyondellBasell, BASF, Dow, ExxonMobil, BP, MOL, Braskem). Preliminary hearings underway; ruling expected Q1 2026. Material increase in litigation exposure and potential damages.
See the full detail →
17 company-specific changes
fiscal period 2025-12-31
filed 2026-02-24
- Material acquisition integration risk newly disclosed. JDE Peet's acquisition introduces substantial operational, financial, and personnel risks that could materially impact business performance and synergy realization.
- New disclosure of material acquisition risk: JDE Peet's deal creates business disruption, customer/supplier uncertainty, key employee retention risk, significant debt financing, and potential stock dilution.
See the full detail →
7 company-specific changes
fiscal period 2025-12-31
filed 2026-02-23
- Added concrete example of $794M after-tax impairment charge on skin health goodwill and intangibles in Q4 2025, demonstrating realized acquisition risk.
- New three-year productivity program with organizational restructuring, supply chain optimization, and overhead reduction. Board-approved July 2025 with material implementation risk and cost uncertainty.
See the full detail →
5 company-specific changes
fiscal period 2025-12-31
filed 2026-02-23
- DISH downgraded from "largest tenant" to past tense; $3.5B+ payment claim and default notice disclosed; $165M net balance sheet impact recognized.
- Escalated executive turnover: CEO terminated mid-year, CFO replaced, new CEO appointed. Pattern of instability worsened materially since prior year.
See the full detail →
2 company-specific changes
fiscal period 2025-12-31
filed 2026-02-23
- Goodwill increased 16% ($7.9B to $9.2B) and new acquisition (Ovivo Electronics) added to impairment risk exposure.
- Total indebtedness increased from $7.6B to $8.2B (8% increase), worsening leverage and debt service obligations materially.
See the full detail →
2 company-specific changes
fiscal period 2025-12-28
filed 2026-02-23
- New disclosure of GLP-1 agonist threat to pizza demand represents a material emerging risk to core business model and revenue.
- Debt maturity schedule shifted materially: $1.18B 2025 payment eliminated; new $470M 2032 obligation added. Covenant thresholds relaxed (5.0x to 5.5x for newer notes), but principal suspension conditions now more complex with multiple leverage ratios.
See the full detail →
4 company-specific changes
fiscal period 2025-12-31
filed 2026-02-23
- New material acquisition with substantial debt assumption, integration risk, restructuring costs, and operational constraints. Reasonable investors would act on these risks.
- Major acquisition (BDS Business) completed post-year-end, introducing substantial integration risks, $4B debt assumption, covenant restrictions, and synergy realization uncertainty.
See the full detail →
3 company-specific changes
fiscal period 2025-12-31
filed 2026-02-23
- Significant new dilution events: 79.8M shares issued for $143M exchangeable notes, new $194.4M exchangeable notes issued, authorized shares doubled to 1.1B, and $40M+ in consent fees payable in shares. Materially escalated dilution trajectory.
- Material litigation risk and debt default threat removed. Noteholder action and related claims no longer disclosed, indicating resolution or settlement of significant legal and financial exposure.
See the full detail →
3 company-specific changes
fiscal period 2025-12-31
filed 2026-02-23
- Added credit rating agency capital/liquidity requirements as binding constraint potentially exceeding regulatory requirements and reducing profitability. Also clarified liquidity mix shift toward lower-yielding securities reduces profitability.
- Concentration in higher-risk commercial loans increased from 69% to 72%, escalating credit risk exposure and potential loss severity.
See the full detail →
6 company-specific changes
fiscal period 2025-12-31
filed 2026-02-20
- Removal of proposed merger risk with IPG eliminates $676M termination fee exposure and strategic uncertainty. Material risk eased through deal completion or termination.
- Merger risk fully resolved. Removal of pending M&A uncertainty, market/employee/client reaction risks, and termination fee exposure materially eases strategic risk.
See the full detail →
2 company-specific changes
fiscal period 2025-12-31
filed 2026-02-20
- New disclosure of actual vendor bankruptcy (September 2025) in North America Automotive segment. Concrete event with supply chain disruption risk, not generic boilerplate.
- Removal of substantial asbestos litigation exposure and broad regulatory compliance risks. Material risk reduction if genuinely resolved or settled.
See the full detail →
1 company-specific change
fiscal period 2025-12-31
filed 2026-02-20
- Removal of comprehensive AI/model risk disclosure eliminates material risk factor covering CECL accounting, credit decisions, pricing, fraud detection, and regulatory capital stress testing.
See the full detail →
5 company-specific changes
fiscal period 2025-12-31
filed 2026-02-20
- New material risk: large capital commitments to serve AI data centers with unproven demand, regulatory approval uncertainty, customer concentration, and potential unrecoverable costs/impairments.
- New executive orders directing DOE to keep coal plants running despite retirement plans directly threaten capital plan execution and environmental goals, creating material regulatory uncertainty.
See the full detail →
2 company-specific changes
fiscal period 2025-12-31
filed 2026-02-20
- Added specific planned CEO transition in May 2026 and AI talent competition. Concrete leadership change escalates succession risk from generic to imminent.
- Added credit card processing exposure, industry standards compliance, and specific consequences (fines, revenue loss, payment processing disruption).
See the full detail →
3 company-specific changes
fiscal period 2025-12-31
filed 2026-02-20
- New disclosure of commercial lease risk: inability to lease space at market rates, below-market rents, and reletting challenges materially affect operations and cash flow.
- Removal of "for taxable years beginning before January 1, 2026" language indicates the 20% deduction is now permanent, materially improving REIT dividend tax treatment and investor attractiveness.
See the full detail →
2 company-specific changes
fiscal period 2025-12-31
filed 2026-02-20
- Removal of material RIE acquisition integration risk signals successful completion or resolution of post-acquisition uncertainties that previously posed material adverse effect risk.
- New disclosure of material data center demand concentration risk, capital intensity, customer credit/termination risks, and technology obsolescence exposure materially worsens operational and financial risk profile.
See the full detail →
8 company-specific changes
fiscal period 2025-12-31
filed 2026-02-20
- Company added $1.725B convertible notes due 2033 and increased credit facility to $1.15B total. Debt materially increased; refinancing risk extended.
- Added specific supply chain constraints: competitors' priority access to servers, memory, co-location capacity, and power now explicitly disclosed as competitive disadvantage affecting costs and availability.
See the full detail →
10 company-specific changes
fiscal period 2025-12-28
filed 2026-02-20
- New disclosure of material tariff, trade war, and export control risks. Company states export restrictions "had a significant impact" on business and identifies specific customer/supplier impacts.
- Multiple new material risks disclosed: NASA budget cuts already impacting 2025 revenues; increased terminations for convenience in Defense Electronics; new EU cybersecurity requirements; January 2026 executive order restricting buybacks, dividends, and executive compensation for major defense contractors.
See the full detail →
8 company-specific changes
fiscal period 2025-12-31
filed 2026-02-20
- Material acquisition integration risk newly disclosed. Worldpay acquisition is substantial strategic transaction with explicit risks to revenue, cost savings realization, customer retention, and management focus.
- Allowance for credit losses more than doubled (109% increase to $50.2M), signaling materially worsened fraud/chargeback risk and higher expected losses.
See the full detail →
5 company-specific changes
fiscal period 2025-12-31
filed 2026-02-20
- New disclosure of multi-year U.S. sales force transformation from independent distributors to employees, with explicit risks of operational disruption, key personnel loss, sales coverage gaps, and revenue impact across multiple markets.
- New disclosure of active portfolio rationalization with concrete execution risks: customer loss, supply chain disruption, inventory obsolescence, asset impairments, and management distraction.
See the full detail →